Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Some hair loss drugs can cause a unique type of hair loss that resembles both psoriasis and alopecia.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Leflunomide is more likely to help treat alopecia areata than cause it.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Upadacitinib may effectively treat alopecia areata without side effects.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

STAT5 activation is crucial for starting the hair growth phase.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Oral processed egg yolk improves hair regrowth and quality in alopecia patients.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Ruxolitinib treatment may cause eyelash growth.

A patch made from human lung fibroblast material helps heal skin wounds effectively, including diabetic ulcers.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Researchers created human hair follicles using a new method that could help treat hair loss.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

SDF-1/CXCL12 and its receptor CXCR4 are crucial for melanocyte movement in mouse hair follicles.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.